Tag: disease modifying therapies
The challenge of accessing MS treatment in Yemen
The Yemeni Association for the Care of Multiple Sclerosis Patients fights for treatment for people with MS
Successful advocacy results in cladribine access for Iran
Adding MS treatments to the WHO Essential Medicines List leads to real-world benefit
People with MS in Albania given new hope with widening access to MS treatment
Fondacioni Pema e Jetës (Tree of Life Foundation) successfully advocated for reimbursed access to MS treatments
El MSIF pone el foco en el uso ético de las terapias modificadoras de la enfermedad no indicadas en la etiqueta para la EM
New publication from MSIF on ethical use of off-label DMTs receives global endorsement
Cómo las diversas terapias modificadoras de la enfermedad pueden retrasar el avance
A new study examined different disease modifying therapies and their ability to slow the onset of secondary progressive MS.
Un estudio demuestra una mejora en los resultados de la situación laboral con EM
New research, involving 874 people who had used disease-modifying therapies during the previous 5 years, has shown a link between more effective disease-modifying therapies and an increased level of employment, work attendance and productivity at work.